Congressional 45-day review period included in reg reform measure approved by Senate Govt. Affairs Cmte.
CONGRESSIONAL 45-DAY REVIEW OF AGENCY RULES INCLUDED IN REG REFORM BILL approved 15-0 by the Senate Governmental Affairs Committee during a March 23 markup. The congressional review provision is taken largely from the "Comprehensive Regulatory Reform Act" (S 343) as reported out by the Senate Judiciary/Oversight & Courts Subcommittee March 14, although the legislation reported out of Government Affairs is based on Committee Chairman Roth's (R-Del.) own regulatory reform bill, S 291.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth